Respiratory Physiology – John B. West Lecture Series Launched by UC San Diego School of Medicine and MediPines

https://www.prnewswire.com/news-releases/respiratory-physiology—john-b-west-lecture-series-launched-by-uc-san-diego-school-of-medicine-and-medipines-300886801.html

ORANGE COUNTY, Calif., July 17, 2019 /PRNewswire/ — UC San Diego School of Medicine and MediPines Corporation, a medical device company based in Orange County, California announce the establishment of the “John B. West Distinguished Lecture Series in Respiratory Physiology and Pathophysiology” to help advance the field of respiratory medicine. The inaugural lecture will feature noted scholar, Joe G. N. Garcia M.D., from the University of Arizona College of Medicine-Tucson and will take place on July 29th, 2019 at the T. Denny Sanford Medical Education and Telemedicine Center, UC San Diego School of Medicine in La Jolla, California.

This distinguished lecture series, established in honor of Dr. John B. West, will bring together leading respiratory science researchers and physiologists to present their research findings to faculty-physicians within the Division of Pulmonary, Critical Care and Sleep Medicine, as well as other local physicians-scientists and clinicians, for the purpose of understanding the latest research and its impact on respiratory medicine. For more information on the lecture series visit the UC San Diego John B. West Lecture Series page.

Dr. West is a world-renowned respiratory physiologist, who has contributed six decades of invaluable research to the field of respiratory physiology and medicine. He is the author of the widely respected medical textbook West’s Respiratory Physiology: The Essentialsnow in its tenth edition. He is also the creator of a series of YouTube videos on respiratory physiology that have influenced the study and clinical practice of many medical students and practitioners worldwide.

“It is a great privilege to establish this lectureship series in honor of Dr. John B. West and his lasting impact on respiratory physiology,” stated Dr. Jason Yuan, Professor and Director of the Section of Physiology, Division of Pulmonary, Critical Care and Sleep Medicine at UC San Diego. “The field of respiratory physiology requires a multi-disciplinary translational approach to scientific advancement and UC San Diego is uniquely positioned to lead such efforts, as UC San Diego School of Medicine is home to Dr. West and several other renowned scientists in the field of respiratory physiology and pathophysiology.” 

UC San Diego School of Medicine’s Section of Physiology of the Division of Pulmonary, Critical Care and Sleep Medicine is home to several noted scholars:

The American Physiological Society Presidents

  • Dr. John B. West, 1984-85
  • Dr. Shu Chien, 1990-91
  • Dr. Peter Wagner, 2010-11
  • Dr. Kim Barrett, 2013-14

American Thoracic Society (ATS) Presidents

  • Dr. Atul Malhotra, 2015-16
  • Dr. Peter D. Wagner, 2005-06
  • Dr. Kenneth Moser, 1985-86 (Former chief of the Division of Pulmonary and Critical Care Medicine,1929-1997)

In addition, the UC San Diego Section of Physiology is the home of the editorial office for the journal, Pulmonary Circulation (Sage), of which Dr. Jason Yuan is the founding Editor-in-Chief. UC San Diego is a leading research institution and clinical hub dedicated to respiratory physiology and lung disease. 

Advancement in respiratory medicine is a national health priority.  A few years ago, a chronic lung disease, chronic obstructive pulmonary disease (COPD), was the fifth leading cause of death in the US. Today, COPD is the third leading cause of death in the US according to the American Lung Association and it is projected to become the world’s leading cause of death in the next 15 years.

COPD and Respiratory Challenges

  • Approximately 33 million Americans suffer from chronic or acute respiratory illness.
  • Respiratory disease accounts for ten percent of all emergency department visits, according to the Centers for Disease Control and Prevention (CDC).
  • In the United States, the economic cost attributed to COPD is estimated to be about $50 billion a year according to the COPD Foundation.
  • Studies estimate that 328 million people worldwide have COPD and it is expected to become the leading cause of death by 2035.

Unfortunately, respiratory disease has received far too little attention and funding in comparison with other major causes of global morbidity and mortality. The result is that respiratory illness is developing into a major public health crisis.

“It is timely that UC San Diego School of Medicine, a scientific and medical authority, is establishing a global forum to discuss medical advancement in the field of respiratory physiology,” stated Steve Lee, CEO of MediPines. “We need a multifaceted approach to tackle this national problem, including medical advancement, industry innovation, and forward-looking government policy. MediPines is delighted to partner with UC San Diego School of Medicine to launch this all-important lecture series in respiratory physiology and medicine.”

MediPines Corporation was established to advance respiratory medicine and it recently launched a novel respiratory device called the MediPines Gas Exchange Monitor, which is based on UC San Diego’s innovative medical technology.

About MediPines:

MediPines Corporation, based in Orange County, California, and maker of the FDA 510(k) cleared MediPines Gas Exchange Monitor, is a pioneering medical device company established to advance respiratory medicine. For more information, email contact@medipines.com, call (949) 398-4670, or visit https://medipines.com.

SOURCE MediPines

Related Links

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida

PR Newswire

ORANGE COUNTY, Calif., April 12, 2019 /PRNewswire/ — Novel physiologic results on world elite freedivers’ using the non-invasive MediPines Gas Exchange Monitor (https://bit.ly/2YVAG1M) were presented at the Experimental Biology 2019 conference. Dr. Philip Ainslie, Co-Director of the Centre for Heart, Lung and Vascular Health at the University of British Columbia, with his research team, conducted the study in Split, Croatia.

MP DIVER

The recently FDA 510(k) cleared, MediPines Gas Exchange Monitor is a breakthrough, portable respiratory monitoring device invented to provide real-time, clinically actionable data. This ground-breaking technology is transforming the approach to measuring pulmonary gas exchange in a wide variety of clinical settings, relevant for the 33 million patients in the US (350 million globally), who suffer from respiratory disease.

The physiological demands placed on these world-class athletes are tremendous. “The transient stress on their lungs is similar to what is observed in patients who suffer from cardiac and respiratory disease.” It has been challenging, in the past, to assess the consequences of deep dives on pulmonary gas exchange, especially during true field-based conditions. “Measuring oxygen deficit has allowed us to establish the impact of ‘lung squeeze’ on gas exchange inefficiency in elite freedivers,” stated Dr. Philip Ainslie.

Oxygen deficit was developed for detecting gas exchange inefficiency using a simple, non-invasive method.  “Understanding gas exchange inefficiency in respiratory patients is fundamental to improving patient outcomes,” according to Dr. John B. West, the world-renowned physiologist who pioneered the concept.

Freedivers place themselves in extreme conditions, which push the outer limits of human lung physiology and can lead to high oxygen deficit. The device provided rapid feedback to the research team tasked with assessing the freedivers’ gas exchange status. “We hope that our device will continue to aid clinicians by providing patients’ respiratory status rapidly and conveniently in situations where direct gas exchange measurement is either difficult or impossible; the device also has clear application to field-based conditions,” said Steve Lee, CEO of MediPines. 

About MediPines:

MediPines Corporation, based in Orange County, California, is a pioneering medical device company established to advance respiratory medicine. For more information, visit https://medipines.com/.

For more information about University of British Columbia’s Centre for Heart, Lung and Vascular Health, visit https://chlvh.ok.ubc.ca/.

(PRNewsfoto/MediPines)
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/fda-cleared-medipines-gas-exchange-monitor-measures-freedivers-lung-efficiency-in-ground-breaking-study-300831089.html

SOURCE MediPines

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

30 Jan 2019 Medical

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the MediPines Gas Exchange Monitor. The MediPines Gas Exchange Monitor provides clinicians with real-time pulmonary parameters and insights to support rapid triage and treatment decisions for respiratory conditions.


The MediPines Gas Exchange Monitor is the first technology of its kind to integrate a comprehensive set of respiratory parameters and innovative indices analyzed from a patient’s normal breathing samples in a simple, easy to administer breathing test in only a few minutes.

SOURCE: https://www.prnewswire.com/news-releases/medipines-announces-fda-clearance-of-breakthrough-respiratory-device-the-medipines-gas-exchange-monitor-300785572.html

Medipines - Clinical Results

Positive Clinical Results Presented at American Thoracic Society (ATS) Conference in San Diego, California.

20 May 2018 Health Care

A group of physicians and researchers presented initial findings at recently held ATS event in San Diego, California where they presented clinical study results, clinical implications and ongoing research areas. Additional opportunities were debated with other medical researchers and broader medical community.

Positive Clinical Results Presented

American Thoracic Society (ATS) Background

American Thoracic Society (ATS) is a nonprofit organization focused on improving care for pulmonary diseases, critical illnesses and sleep-related breathing disorders. It was established in 1905. It is the largest gathering of physicians, researches and clinicians in the respiratory fields, and recent gathering had about 15,000 attendees from around the world in San Diego. For more on ATS, please visit www.thoracic.org

Clinical Trial Results Published in CHEST - Medipines

Clinical Trial Results Published in CHEST Demonstrate Feasibility for Non-Invasive Gas Exchange Concept.

13 Feb 2018 Health Care

Non-invasive way to measure the degree of impaired gas exchange has been proposed and published with supporting study results.CHEST is a peer-reviewed medical journal covering chest diseases and related issues including pulmonology, cardiology, breathing, airway diseases and emergency medicine. The journal was established in 1935. For more on CHEST, https://journal.chestnet.org/

Clinical Trial Results Published

Search

+